In the presence of bortezomib, downregulation of miR-34a increased apoptosis of P493-6 cellsmiR-34a overexpression in TP53-mutated MM cell lines and mice inhibited tumor growth. The gene discussed is TP53; the disease is Miyoshi myopathy.